Literature DB >> 21554218

The relevance of drug volume of distribution in antibiotic dosing.

Marta Ulldemolins1, Jordi Rello.   

Abstract

Despite the importance of early an appropriate therapy for the outcomes of severe infections in critically ill patients, there is still little understanding of dose optimization during the most important phase of the treatment, the initial phase. Disease-driven variations in pharmacokinetics and pharmacokinetics/ pharmacodynamics may compromise the therapeutic success of antibiotic therapy. Therefore, dose adjustments that account for these variations are paramount for improving antibiotic use in critically ill patients. Compelling evidence shows significant increases in the Vd of both hydrophilic and lipophilic drugs in critically ill patients as a consequence of patient pathology and from clinical interventions. These increases in the Vd can lead to lower than expected plasma concentrations during the first day of therapy, which may result in sub-optimal achievement of antibiotic pharmacokinetics/pharmacodynamic targets, resulting in inappropriate treatment. Therefore, loading doses of antibiotic during the first day of therapy that account for the predicted increase in the Vd are required. Further research towards the establishment of new dosing regimens that use loading doses to satisfy such increased volumes of distribution is recommended.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554218     DOI: 10.2174/138920111798808365

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  10 in total

Review 1.  Considerations for analgosedation and antithrombotic management during extracorporeal life support.

Authors:  Pamela K Burcham; Alan J Rozycki; Erik E Abel
Journal:  Ann Transl Med       Date:  2017-02

2.  Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance.

Authors:  Stephen Y Liang; Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

3.  Septic shock in the era of precision medicine.

Authors:  Jordi Rello; Francisco Valenzuela-Sánchez
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

4.  A Physiologically Based Pharmacokinetic Perspective on the Clinical Utility of Albumin-Based Dose Adjustments in Critically Ill Patients.

Authors:  Huybrecht T'jollyn; An Vermeulen; Jan Van Bocxlaer; Pieter Colin
Journal:  Clin Pharmacokinet       Date:  2018-01       Impact factor: 6.447

5.  Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.

Authors:  Chunlu Gao; Jing Tong; Kaijiang Yu; Zhidan Sun; Ran An; Zhimin Du
Journal:  Eur J Clin Pharmacol       Date:  2016-03-29       Impact factor: 2.953

6.  A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics.

Authors:  Darren M Roberts; Xin Liu; Jason A Roberts; Priya Nair; Louise Cole; Michael S Roberts; Jeffrey Lipman; Rinaldo Bellomo
Journal:  Crit Care       Date:  2015-03-13       Impact factor: 9.097

Review 7.  Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.

Authors:  Marta Ulldemolins; Sergi Vaquer; Mireia Llauradó-Serra; Caridad Pontes; Gonzalo Calvo; Dolors Soy; Ignacio Martín-Loeches
Journal:  Crit Care       Date:  2014-06-23       Impact factor: 9.097

Review 8.  Optimizing antimicrobial therapy in critically ill patients.

Authors:  Virginie Vitrat; Serge Hautefeuille; Cécile Janssen; David Bougon; Michel Sirodot; Leonardo Pagani
Journal:  Infect Drug Resist       Date:  2014-10-20       Impact factor: 4.003

9.  Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units.

Authors:  Elodie Matusik; Justine Lemtiri; Guillaume Wabont; Fabien Lambiotte
Journal:  BMC Nephrol       Date:  2022-01-29       Impact factor: 2.388

Review 10.  An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.

Authors:  Anand Kumar
Journal:  Virulence       Date:  2013-11-01       Impact factor: 5.882

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.